Showing 1 - 4 results of 4 for search 'Jiazhuo Wu', query time: 0.02s Refine Results
  1. 1
    P1229: PARP INHIBITORS ARE EFFECTIVE IN NATURAL KILLER/T CELL LYMPHOMA VIA THE EXPRESSION OF LMO2

    P1229: PARP INHIBITORS ARE EFFECTIVE IN NATURAL KILLER/T CELL LYMPHOMA VIA THE EXPRESSION OF LMO2 by Jiazhuo Wu, Mingzhi Zhang

    Published 2023-08-01
    Get full text
    Article
  2. 2
    PARP inhibitor exerts an anti-tumor effect via LMO2 and synergizes with cisplatin in natural killer/T cell lymphoma

    PARP inhibitor exerts an anti-tumor effect via LMO2 and synergizes with cisplatin in natural killer/T cell lymphoma by Jiazhuo Wu, Cunzhen Shi, Hongwen Li, Wenting Song, Shuo Huang, Jianxiang Zhang, Wencai Li, Zhaoming Li, Mingzhi Zhang

    Published 2023-07-01
    Get full text
    Article
  3. 3
    A second‐generation CD38‐CAR‐T cell for the treatment of multiple myeloma

    A second‐generation CD38‐CAR‐T cell for the treatment of multiple myeloma by Hongwen Li, Jing Li, Jiazhuo Wu, Zhuangzhuang Shi, Yuyang Gao, Wenting Song, Jiwei Li, Zhaoming Li, Mingzhi Zhang

    Published 2023-05-01
    Get full text
    Article
  4. 4
    CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma

    CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma by Hongwen Li, Wenting Song, Jiazhuo Wu, Zhuangzhuang Shi, Yuyang Gao, Jiwei Li, Lijuan Han, Jianxiang Zhang, Zhaoming Li, Yong Li, Mingzhi Zhang

    Published 2023-08-01
    Get full text
    Article

Search Tools: